FDA: Popular Brand of Insulin Found to Contain Cancer-Causing Impurity
A popular brand of insulin has been found to contain potentially life-threatening impurities, health officials say.
Researchers have found that Metformin, a type of insulin used to treat Type 2 diabetics, contains nitrosamines, the FDA announced Monday. Nitrosamines, or NDA, is a known environmental contaminant that’s classified as a probable human carcinogen, which means it ingesting it could cause cancer. However, researchers say their investigation is ongoing and patients who use Metformin should wait before discontinuing the treatment.
“The FDA recommends prescribers continue to use Metformin when clinically appropriate,” says the FDA’s Janet Woodcock. “There are no alternative medications that treat this condition in the same way.” The FDA notes while many foods contain NDMA, ingesting more than 96 nanograms a day is considered risky. “Improved technology enables us to detect even trace amounts of impurities in drug products and may be the reason why more products have been found to have low levels of NDMA,” a statement from the agency reads.
Common diabetes drug metformin is being investigated in US and Europe over fears it may contain cancer-causing chemicalhttps://t.co/pQxhus6kl6
— Daily Mail Online (@MailOnline) December 10, 2019
